Health Canada

Australian MPs Admit They Tried Cannabis, Signaling Policy Reform & Epidiolex For Seizures Approved In Canada
Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates
Medical Cannabis In Canada Faces Decline: What's Behind The 38% Drop In Registrations?
Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates
Medical Cannabis In Canada Faces Decline: What's Behind The 38% Drop In Registrations?
Packaging, Potency And Demand: How Health Canada's THC Limits May Impact Cannabis Markets
Organigram Takes On Health Canada In Battle For Cannabis Ingestible Extracts Freedom

Health Canada Recent News

How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
Licensed psychedelic drugs producer Optimi Health Corp. (OTCQX: OPTHF) submitted a Health Canada clinical trial application (CTA) for a Phase 1 study that will assess the safety of combining its natural psilocybin standardized extract with its proprietary MDMA drug candidate in healthy therapists.
Medical Cannabis Growers' Privacy Upheld By Canadian Federal Court
In Canada, a Federal Court ruled that data on the locations of large-scale medical cannabis growers will be protected from disclosure, reported The Globe And Mail. What Happened
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as post-traumatic stress disorder and psilocybin for treatment-resistant depression.
Canadian Cannabis Companies Being Told To 'Voluntarily Undertake Actions' Here's What's Happening
Health Canada recently required several cannabis companies to stop selling certain products on the grounds that they were incorrectly labeled as extracts rather than edibles.
Canadian Weed Companies Ordered To Stop Selling Certain Cannabis Extracts, Could Cost Them Millions
Canadian cannabis companies have been required to stop selling certain ingestible cannabis products, which could cost the industry millions. 
These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year
What a year for psychedelics!
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
First Take-Home Psychedelics Clinical Trial In North America Will Target PTSD
Vancouver-based psychedelics biopharma company Apex Labs Ltd.
Health Canada Grants Dealer's License To University Scientists For Magic Mushroom Cultivation
Ontario Agricultural College’s Department of Plant Agriculture University of Guelph (UG) professors and researchers Dr. Max Jones and Dr. Gale Bozzo received approval by the federal agency Health Canada to study psilocybin mushrooms.
Psyched: DEA Boosts Research Production, Booker's Psychedelics Reform, Kanye West's George Floyd Comments And More
DEA Boosts Production Of Cannabis & Psychedelics For Research In 2023 The DEA is proposing that 6.7 million grams (14,770 pounds) of marijuana be grown for research, more than double the amount suggested for 2022 (3.2 million grams). 
Canada Update: Psychedelics Legal Landscape, Overview & Near-Term Predictions
Canada is hosting discussions on legal access to psychedelic-assisted therapies, especially after Alberta passed regulatory measures for this type of health s
Mushroom Tea For Use In Psychedelic Research Developed By Numinus Wellness
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and evidence-based psychedeli
Two Psychedelics Companies Will Study Effects Of Natural Psilocybin And MDMA In Healthy Volunteers
Health Canada receives applications concerning clinical trials on a regular basis.  This time, the licensed producer of natural EU-GMP psilocybin and MDMA Optimi Health Corp.
Canada Studies Effects Of Psilocybin For COVID Frontline Healthcare Workers In Phase 2 Clinical Trial
Alberta-based ATMA Journey Centers Inc.
Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics
Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog.
First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural psilocybin and other psychedelic substances, announced that it has entered into its first international psi
Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead
Optimi Health Corp.
Health Canada Confirms It: CBD Is 'Safe And Tolerable'
According to a report titled “Review of cannabidiol: Report of the Science Advisory Committee on Health Products Containing Cannabis,” publishe
Canada: MDMA-Assisted Therapy Trials Reviewed By Health Canada, Here's What's Happening
Health Canada has just completed a review of all active MDMA-assisted psychotherapy trials, in response to alleged patient safety issues and research flaws. The issues had resulted in one of the two existing studies being suspended while the other allowed to proceed with some "corrective and preventive" changes.
Psychedelics Company Nabs Health Canada Construction Permit, Find Out How They Got It
Canadian life sciences company Nirvana Life Sciences Inc. (CSE: NIRV), focused on research & development of non-addictive pain management and relapse prevention products for pain and addictions, has been granted approval to build its R&D facility in Vancouver by Canada’s governmental department of Health.
Canada Approves Amylyx's ALS Drug; FDA To Consider Approval In September
The Canadian government has given its approval to AMX0035, a new drug from Cambridge, Massachusetts-based Amylyx Pharmaceuticals Inc.
Hempsana Holdings Receives Health Canada's Approval To Sell Medical Cannabis Directly To Patients Across Canada
Hempsana Holdings Ltd. has received its medical sales license from Health Canada which provides the company the ability to sell cannabis products directly to medical patients across Canada.
MediPharm Labs Shares Slightly Up On Obtaining Export Authorization To Ship Medical Cannabis To Brazil
Cannabis-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced Wednesday that it had obtained approval from ANVISA and Health Canada to ship medical cannabis oil to Brazil.